Literature DB >> 8387478

Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone.

H Chiba1, N Sawada, T Ono, S Ishii, M Mori.   

Abstract

We established a human osteoblastic cell line immortalized by simian virus 40 (SV40) in vitro, and designated it SV-HFO. Immunocytochemically, the cells were positive for SV40 large T-antigen, vimentin and osteocalcin, but negative for keratin and epithelial membrane antigen. The cells had characteristic morphologic and ultrastructural features of osteoblasts, produced alkaline phosphatase, and synthesized osteocalcin, the levels of which were elevated by treatment of the cells with 1a,25-dihydroxyvitamin D3. The cells proliferated and showed such osteoblastic properties even under serum-free conditions. The cells grew in soft agar, but did not form tumors when transplanted into athymic nude mice. Karyotypic analysis by the Q-banding technique showed that these cells were of human origin. The SV-HFO cell line is expected to serve as a suitable model for studying metabolism and carcinogenesis in human bone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387478      PMCID: PMC5919145          DOI: 10.1111/j.1349-7006.1993.tb02869.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


simian virus 40: HFO, human fetal osteoblastic cells Dulbecco's modified Eagle's medium fetal bovine serum passage SV40‐transformed human fetal osteoblastic cells alkaline phosphatase 1α,25‐dihydroxyvitamin D3 monoclonal antibody epithelial membrane antigen population doublings
  26 in total

1.  Differential properties among clones of simian virus 40-transformed human epithelial cells.

Authors:  M E Kaighn; K S Narayan; Y Ohnuki; L W Jones; J F Lechner
Journal:  Carcinogenesis       Date:  1980-08       Impact factor: 4.944

2.  Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.

Authors:  B J Christian; L J Loretz; T D Oberley; C A Reznikoff
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

3.  Clonal osteogenic cell lines express myogenic and adipocytic developmental potential.

Authors:  A Yamaguchi; A J Kahn
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

4.  Histochemical detection of osteocalcin in normal and pathological human bone.

Authors:  A H Vermeulen; C Vermeer; F T Bosman
Journal:  J Histochem Cytochem       Date:  1989-10       Impact factor: 2.479

5.  Rat calvarial cell lines immortalized with SV-40 large T antigen: constitutive and retinoic acid-inducible expression of osteoblastic features.

Authors:  J K Heath; S B Rodan; K Yoon; G A Rodan
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

6.  1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.

Authors:  R T Franceschi; W M James; G Zerlauth
Journal:  J Cell Physiol       Date:  1985-06       Impact factor: 6.384

7.  Osteocalcin secretion by the human osteosarcoma cell line MG-63.

Authors:  D Lajeunesse; C Frondoza; B Schoffield; B Sacktor
Journal:  J Bone Miner Res       Date:  1990-09       Impact factor: 6.741

8.  Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3.

Authors:  K G Yoon; S J Rutledge; R F Buenaga; G A Rodan
Journal:  Biochemistry       Date:  1988-11-15       Impact factor: 3.162

9.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone.

Authors:  A E Grigoriadis; J N Heersche; J E Aubin
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

10.  Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production.

Authors:  J E Aubin; J N Heersche; M J Merrilees; J Sodek
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  5 in total

1.  Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway.

Authors:  Andrea M Brum; Jeroen van de Peppel; Cindy S van der Leije; Marijke Schreuders-Koedam; Marco Eijken; Bram C J van der Eerden; Johannes P T M van Leeuwen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

2.  Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study.

Authors:  Justus H W Jansen; Olav P van der Jagt; Bas J Punt; Jan A N Verhaar; Johannes P T M van Leeuwen; Harrie Weinans; Holger Jahr
Journal:  BMC Musculoskelet Disord       Date:  2010-08-23       Impact factor: 2.362

3.  Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition.

Authors:  Molly Brunner; Angélique Millon-Frémillon; Genevieve Chevalier; Inaam A Nakchbandi; Deane Mosher; Marc R Block; Corinne Albigès-Rizo; Daniel Bouvard
Journal:  J Cell Biol       Date:  2011-07-18       Impact factor: 10.539

4.  The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading.

Authors:  K Iba; R Albrechtsen; B Gilpin; C Fröhlich; F Loechel; A Zolkiewska; K Ishiguro; T Kojima; W Liu; J K Langford; R D Sanderson; C Brakebusch; R Fässler; U M Wewer
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

5.  Iodothyronine deiodinase enzyme activities in bone.

Authors:  Allan J Williams; Helen Robson; Monique H A Kester; Johannes P T M van Leeuwen; Stephen M Shalet; Theo J Visser; Graham R Williams
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.